159 related articles for article (PubMed ID: 14634493)
21. Reductions in and relations between "craving" and drinking in a prospective, open-label trial of ondansetron in adolescents with alcohol dependence.
Dawes MA; Johnson BA; Ma JZ; Ait-Daoud N; Thomas SE; Cornelius JR
Addict Behav; 2005 Oct; 30(9):1630-7. PubMed ID: 16084024
[TBL] [Abstract][Full Text] [Related]
22. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
23. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
[TBL] [Abstract][Full Text] [Related]
24. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
25. Ondansetron and pruritus in chronic liver disease: a controlled study.
Jones EA; Molenaar HA; Oosting J
Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of DSM-IV alcohol diagnostic orphans: drinking patterns, physical illness, and negative life events.
McBride O; Adamson G; Bunting BP; McCann S
Drug Alcohol Depend; 2009 Jan; 99(1-3):272-9. PubMed ID: 18848409
[TBL] [Abstract][Full Text] [Related]
27. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron.
Dizdar V; Gilja OH; Hausken T
Neurogastroenterol Motil; 2007 Dec; 19(12):977-82. PubMed ID: 17973637
[TBL] [Abstract][Full Text] [Related]
28. The effect of Ondansetron on memory in schizophrenic patients.
Levkovitz Y; Arnest G; Mendlovic S; Treves I; Fennig S
Brain Res Bull; 2005 Apr; 65(4):291-5. PubMed ID: 15811593
[TBL] [Abstract][Full Text] [Related]
29. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
Bolton JM; Robinson J; Sareen J
J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
Johnson BA; Ait-Daoud N; Seneviratne C; Roache JD; Javors MA; Wang XQ; Liu L; Penberthy JK; DiClemente CC; Li MD
Am J Psychiatry; 2011 Mar; 168(3):265-75. PubMed ID: 21247998
[TBL] [Abstract][Full Text] [Related]
31. Classifying mood disorders by age-at-onset instead of polarity.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
[TBL] [Abstract][Full Text] [Related]
32. Desipramine treatment of alcoholism.
Mason BJ; Kocsis JH
Psychopharmacol Bull; 1991; 27(2):155-61. PubMed ID: 1924663
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
34. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
35. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
36. Depression and social phobia secondary to alcohol dependence.
Olgiati P; Liappas I; Malitas P; Piperi C; Politis A; Tzavellas EO; Zisaki A; Ferrari B; De Ronchi D; Kalofoutis A; Serretti A
Neuropsychobiology; 2007; 56(2-3):111-8. PubMed ID: 18182831
[TBL] [Abstract][Full Text] [Related]
37. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
[TBL] [Abstract][Full Text] [Related]
38. [Effect of angiotensin II synthesis inhibition on alcohol consumption].
Guivernau M; Pallavicini J
Rev Med Chil; 2008 Aug; 136(8):968-75. PubMed ID: 18949179
[TBL] [Abstract][Full Text] [Related]
39. Lifetime rates of alcoholism in adults with anxiety, depression, or co-morbid depression/anxiety: a community survey of Ontario.
Gratzer D; Levitan RD; Sheldon T; Toneatto T; Rector NA; Goering P
J Affect Disord; 2004 Apr; 79(1-3):209-15. PubMed ID: 15023496
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function.
Brinkworth GD; Buckley JD; Noakes M; Clifton PM; Wilson CJ
Arch Intern Med; 2009 Nov; 169(20):1873-80. PubMed ID: 19901139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
